WHO PREQUALIFICATION IN NIGERIA PHARMA INDUSTRY PERSPECTIVE CHIEF OLUBUNMI OLAOPA OCTOBER 30, 2013
|
|
|
- Paul Bruce
- 10 years ago
- Views:
Transcription
1 WHO PREQUALIFICATION IN NIGERIA PHARMA INDUSTRY PERSPECTIVE CHIEF OLUBUNMI OLAOPA OCTOBER 30, 2013
2 OUTLINE NIGERIAN PHARMA SECTOR PRINCIPLE OF WHO PREQUALIFICATION PRODUCTS OF INTEREST FOR WHO PQP PROCESS OF WHO PREQUALIFICATION PROGRESS SO FAR BY NIGERIA BENEFITS OF THE WHO PQP SO FAR CHALLENGES TO WHO PQP CRITICAL SUCCESS FACTORS
3 NIGERIAN PHARMA SECTOR LOCAL MANUFACTURE OF MEDICINES ENCOURAGED WITH OVER 120 MANUFACTURERS REGULATION OF PRODUCTS IS BY THE NATIONAL AGENCY FOR FOOD & DRUG ADMINISTRATION & CONTROL(NAFDAC) PMG-MAN PROMOTES GMP AND UPHOLDS QUALITY ASSURANCE STANDARDS IN NIGERIA THROUGH SELF REGULATION MECHANISMS
4 PRINCIPLE OF WHO PREQUALIFICATION WHO PREQUALIFICATION refers to the standardized quality assessment procedures put in place to evaluate the acceptability of pharmaceutical products. The purpose is to evaluate whether certain products meet requirements recommended by The WHO and are manufactured in compliance with current codes of GMP
5 PRINCIPLE OF WHO PREQUALIFICATION Applies unified standards of acceptable quality, safety and efficacy. Comprehensively evaluates the quality, safety and efficacy of medicinal products, based on information submitted by the manufacturers, and inspection of the corresponding manufacturing and clinical sites. 5
6 WHO-PREQUALIFICATION Prequalification Programme A United Nations Programme managed by WHO or In close cooperation with national regulatory agencies and partner organizations, the Prequalification Programme aims to make quality priority medicines available for the benefit of those in need. This is achieved through its evaluation and inspection activities, and by building national capacity for sustainable manufacturing and monitoring of quality medicines 6
7 PRODUCTS OF INTEREST PRODUCTS ARTEMISIN COMBINATION THERAPIES INDICATIONS MALARIA ANTI-RETROVIRAL MEDICINES FLUCONAZOLE Cycloserine, Ethambutol Pyrazinamide Oxytocics ZINC SULPHATE HIV/AIDS OPPORTUNISTIC INFECTIONS Tuberculosis REPRODUCTIVE HEALTH MNCH COMMODITIES
8 WHO PREQUALIFICATION INAFRICA - There is no local pharmaceutical manufacturer in Nigeria or in the entire West Africa pre-qualified by the WHO but there are some in Africa such as: Aspen Pharmacare Ltd Port Elizabeth - Republic of SOUTH AFRICA(2007) Maphar SA Casablanca - MOROCCO (2008) Quality Chemical Industries Ltd (QCIL) - Kampala - UGANDA (2010)
9 Steps STEin prequalification PREQUALIFICATION PROCESS Expression of Interest. Product dossier. SMF Assessment Inspections Additional information and data Corrective actions Compliance Compliance Prequalification Monitorin 9
10 MOTIVATION FOR WHO PREQUAL. BY NIGERIA Conforming to International Requirements such as the UN systems Possibilities of participation in international tenders Facilitated registration for export and Donor transactions Prestige and national pride
11 PRE-QUALIFICATION PROCESS & ACTIVITIES Expression of Interest Upgrade of GMP Facilities Capacity Building & GMP training Pre-Inspection Visits by WHO Implementation Of CAPA Selection of Products for Prequalification
12 Packaging Hall
13 Tableting Suites
14 Air Handling Unit
15 Air Handling Unit
16 GMP Compliant Warehouse
17 INSTRUMENTS LABORATORY
18 NEXT STEPS Continuous GMP upgrade Continuous Capacity Building Implementation Of CAPA Final WHO audit Publication of WHO Public Inspection Report Development of Dossiers Bio-equivalence & Bio-availability Studies WHO Prequalifivation
19 FINAL OUTCOME= ENLISTMENT OF MEDICINES If the product is found to meet the specified requirements, and the manufacturing site complies with GMP, both the product linked to this manufacturing site and company are added to a list hosted by WHO on a public web site. 19
20 PROGRESS SO FAR BY NIGERIA STATUS EXPRESSION OF INTEREST UPGRADED FACILITIES ALREADY INSPECTED BY WHO NEW FACTORIES ALREADY INSPECTED BY WHO NEW FA TORIES PENDING COMPLETION COMPANIES ELEVEN COMPANIES EVANS MEDICAL PLC NEIMETH PHARM PLC SWISSPARMA LIMITED CHI PHARMA LTD JUHEL NIGERIA LTD MAY & BAKER NIG. PLC AFRABCHEM LTD DAILY NEED IND LTD EMZOR PHARM IND LTD IND FIDSON HEALTHCARE PLC PHAMA TEX INDUSTRIES LIMITED
21 Benefits of the WHO PQ Process to Nigeria Better Appreciation Of The Tenets Of Good Manufacturing Practice (GMP) Quality Improvement & Upgrade Of Manufacturing Facilities Investment in New Factories Investment in Capacity building Improved collaborations between Industry & Regulators
22 Benefits of the WHO PQ Process to Nigeria Access to WHO, UNICEF & The UN System, Regular Training in aspects of GMP & Quality assurance Local Industry developing new products for Mothers Children & Newborns such as Zinc Sulphate & Chlorhexidine gel Better Prospects For Patronage from Government Agencies
23 CURRENT CHALLENGES TO PQ Sourcing Quality Active Pharma Ingredients Human Resource & Expertise Quality Of Submissions/Dossiers Resources For Bio Equivalence Studies Services Of Contract Research Organizations (CROs) Guaranty Of Patronage
24 FINANCIAL COST OF PRE- QUALIFICATION Nigerian Pharmaceutical Manufacturers processing WHO Prequalification have invested more than N70 Billion or $450m so far Financial & Technical Support have been received from WAHO & WHO/UNITAID Special Funding package expected from ECOWAS Bank for International Development & African Development Bank
25 UGANDAN EXPERIENCE World Health Organization (WHO) certified the facility as a contract manufacturing plant for CIPLA Limited, India and then began approving manufactured medicines. QCIL is also accredited by the International Committee of the Red Cross Drugs for Neglected Diseases Initiative (DNDi), Pharmacy and Poisons Board of Kenya, Tanzania Food & Drug Authority (TFDA), and the National Drug Authority of Uganda(NDA).
26 AREAS FOR SUPPORT Expertise & Resources for GMP Expertise & Resources for DOSSIER DEVELOPMENT Resources for BIO-EQUIVALENCE Contract Research Organizations required in West Africa Funding Patronage
27 CRITICAL SUCCESS FACTORS FOR PREQUALIFICATION PROCESS Political Will of Regulator & Government Determination of Industry & Advocacy Expertise and Human Resources Technical Assistance & International Support Choice Of Products For Prequalification Availability of Finance Guarantee of Patronage
28 THE WAY FORWARD FOR ECOWAS Sustained Advocacy Engagements With WHO & Partners Continuous Support From WAHO Long Term Funding Required WAHO Certification As A Stepping Stone Bio-availability-bio-equivalence Centre Required In ECOWAS
29 CONCLUSION The WHO Prequalification Process has POSITIVELY IMPACTED the Nigerian Pharmaceutical Industry through improved standards and eligibility for international tenders. We expect as many as FIVE NIGERIAN MANUFACTURERS to have products prequalified by the World Health Organization in 2014.
30 THANK YOU
EXPERT REVIEW PANEL PROCEDURE: ADDITIONAL SUPPORT TO PROCUREMENT AGENCIES UNDER EXCEPTIONAL CIRCUMSTANCES
EXPERT REVIEW PANEL PROCEDURE: ADDITIONAL SUPPORT TO PROCUREMENT AGENCIES UNDER EXCEPTIONAL CIRCUMSTANCES Introduction The WHO Prequalification of Medicines Programme (PQP) was established to provide UN
Food, Medicine and Health Care Administration and Control Authority
Food, Medicine and Health Care Administration and Control Authority Bio equivalence Study Registration Requirements in Ethiopia (Four Countries Experience) Mengistab W.Aregay (Bpharm, MSc. in Health Monitoring
Speeding up access to markets: WHO Expert Review Panel & WHO accelerated registration procedure How manufacturers, procurers and patients benefit
Speeding up access to markets: WHO Expert Review Panel & WHO accelerated registration procedure How manufacturers, procurers and patients benefit JOINT UNICEF, UNFPA & WHO MEETING WITH MANUFACTURERS AND
PROJECT INFORMATION DOCUMENT (PID) ADDITIONAL FINANCING Report No.: PIDA26027. Project Name Parent Project Name. Region Country
PROJECT INFORMATION DOCUMENT (PID) ADDITIONAL FINANCING Report No.: PIDA26027 Project Name Parent Project Name Region Country Africa Medicine Regulatory Harmonization Project (P155163) AFCC2/RI-African
Session 6: WHO Prequalification Programme. Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs
Session 6: WHO Prequalification Programme Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs Session adapted from the WHO training workshop on prequalification and the WHO technical briefing seminar
AFRICAN UNION ROADMAP: PROGRESS IN THE FIRST YEAR
AFRICAN UNION ROADMAP: PROGRESS IN THE FIRST YEAR Update on progress to implement the African Union Roadmap on Shared Responsibility and Global Solidarity for AIDS, TB and Malaria Response in Africa (2012
PATENT ISSUES & LOCAL PHARMACEUTICAL PRODUCTION IN GHANA. By Kwasi Poku Boateng QUALITY MANAGEMENT CONSULTANT
PATENT ISSUES & LOCAL PHARMACEUTICAL PRODUCTION IN GHANA By Kwasi Poku Boateng QUALITY MANAGEMENT CONSULTANT International Conference on Local Pharmaceutical Production in Africa, Cape Town, April 4-6,
Iamey/AbWEST AFRICAN HEATH ORGANIZATION PROCEDURE GUIDELINE FOR THE MANAGEMENT OF THE REGIONAL ANTIRETROVIRAL DRUGS BUFFER STOCK
Page 1 of 54 Iamey/AbWEST AFRICAN HEATH ORGANIZATION PROCEDURE GUIDELINE FOR THE MANAGEMENT OF THE REGIONAL ANTIRETROVIRAL DRUGS BUFFER STOCK Addressee: West African Heath Organization (WAHO), Central
UNICEF s Quality Assurance System for procurement of medicines
UNICEF s Quality Assurance System for procurement of medicines QA Specialist Peter Svarrer Jakobsen Joint UNICEF, UNFPA and WHO Meeting with Manufacturers and Suppliers UN City, Copenhagen 23 September
NRA FUNCTION IN CONTROLLING VACCINES IN CLINICAL TRIAL AND MARKETING AUTHORIZATION INDONESIA 2013 DVI MEETING 9 11 APRIL 2013 1
NRA FUNCTION IN CONTROLLING VACCINES IN CLINICAL TRIAL AND MARKETING AUTHORIZATION INDONESIA 2013 DVI MEETING 9 11 APRIL 2013 1 2 The National Agency of Drug and Food Control (NA-DFC) is a non departmental
The European regulatory system for medicines and the European Medicines Agency
The European regulatory system for medicines and the European Medicines Agency A consistent approach to medicines regulation across the European Union An agency of the European Union This booklet is intended
QA for LN Procurement by UNICEF Supply Division
UNICEF Supply Division Copenhagen QA for LN Procurement by UNICEF Supply Division Jolanta Wozniak Quality Assurance Centre Agenda The UNICEF Supply Division Model UNICEF QA Introduction Inspections Regulatory
ITEM FOR ESTABLISHMENT SUBCOMMITTEE OF FINANCE COMMITTEE
For discussion on 8 June 2011 EC(2011-12)2 ITEM FOR ESTABLISHMENT SUBCOMMITTEE OF FINANCE COMMITTEE HEAD 37 DEPARTMENT OF HEALTH Subhead 000 Operational expenses Members are invited to recommend to Finance
Session 4: The Drug Management Cycle: Selection. David Peters
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
Overview of WHO revised vaccine prequalification procedure
Overview of WHO revised vaccine prequalification procedure Carmen Rodriguez WHO/IVB/QSS Vaccine Industry Consultation meeting 25-26 January 2012 UNICEF SD Copenhagen Purpose of WHO vaccines prequalification
Annex 3 Procedure for prequalification of pharmaceutical products
World Health Organization WHO Technical Report Series, No. 953, 2009 Annex 3 Procedure for prequalification of pharmaceutical products 1. Introduction 2. Glossary 3. Purpose and principles 4. Steps of
Bioequivalence Study Design Considerations. Dr. John Gordon
Bioequivalence Study Design Considerations Dr. John Gordon Key Output of Programme A list of prequalified medicinal products used for treatment of HIV/AIDS, malaria, tuberculosis, influenza, and for reproductive
CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS
CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS Overview 6.1 This chapter sets out the Review Committee s findings and recommendations on procurement
Annex 10 Procedure for prequalification of pharmaceutical products
World Health Organization WHO Technical Report Series, No. 961, 2011 Annex 10 Procedure for prequalification of pharmaceutical products 1. Introduction 2. Glossary 3. Purpose and principles 4. Steps of
Clinical Trial Logistics
Company Brochure Clinical Trial Logistics contents 1. 2. 3. 4. 5. 6. About us Values Facility Quality Management System Services Why PCS Clinical Trial Logistics about us MEET US PHARMA COMPLEX SOLUTIONS
UNICEF s Supply Function and Work in Supply of Medicines
UNICEF s Supply Function and Work in Supply of Medicines UNICEF structure UNICEF has four organizational groups: external relations, management, programmes and resource mobilisation. Supplies are an integral
The WHO Prequalification of Medicines Programme
The WHO Prequalification of Medicines Programme CPTR 2013 Workshop, Washington 1-3 Oct 2013 Dr M Stahl Head of Assessments, Prequalification of Medicines Programme WHO 1 The Prequalification of Medicines
REQUEST FOR EXPRESSION OF INTEREST ofl_ (Individual Consulting Services) To Support the Management of the
REQUEST FOR EXPRESSION OF INTEREST ofl_ (Individual Consulting Services) To Support the Management of the West Africa Regional Disease Surveillance Capacity Strengthening Project (WARDS Project) Sahel
The Pharmaceutical Manufacturing Plan for Africa Business Plan (PMPA BP)
IPC Meeting, World Bank, Washington D.C., 11-12 Dec 2012 The Pharmaceutical Manufacturing Plan for Africa Business Plan (PMPA BP) Juergen Reinhardt Project Manager Business, Investment and Technology Services
GMP Pharma BV. Netherlands
GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization
The Rapidly Evolving Regulatory Landscape in Africa
The Rapidly Evolving Regulatory Landscape in Africa B. Dicky Akanmori Regional Advisor, Vaccine Regulation Immunization, Vaccines & Emergencies Cluster What has changed? Prime targets for vaccine development
TREATING DRUG-SENSITIVE TB IN INDIA: IMPLEMENTATION OF DAILY THERAPY WITH FIXED DOSE COMBINATIONS
TREATING DRUG-SENSITIVE TB IN INDIA: IMPLEMENTATION OF DAILY THERAPY WITH FIXED DOSE COMBINATIONS Policy brief, March 2015 Tuberculosis (TB), a communicable disease that affects 9 million people worldwide,
US Regulations for Import and Export of Cell Therapy Products
US Regulations for Import and Export of Cell Therapy Products Kurt Gunter, MD U Minnesota UCB Transplants (2001-2007)* Total units: 790 Number US banks: 19 Number non-us banks: 12 % units from non-us banks:
Kenya Pharmaceutical Sector Development Strategy
Kenya Pharmaceutical Sector Development Strategy Kenya Pharmaceutical Sector Development Strategy Global UNIDO Project: Strengthening the local production of essential medicines in least developed and
The Contribution of Traditional Medicine in Treatment and Care in HIV/AIDS- The THETA Experience in Uganda
The Contribution of Traditional Medicine in Treatment and Care in HIV/AIDS- The THETA Experience in Uganda THETA background information THETA is an acronym that stands for: Traditional and modern Health
QUESTIONS AND ANSWERS ABOUT THE EDQM ACTIVITIES
QUESTIONS AND ANSWERS ABOUT THE EDQM ACTIVITIES Why are Pharmacopoeias so important in a globalised world? Pharmacopoeias have historically provided collections of medical recipes intended to ensure accurate
Drug Regulations in India Dr. Surinder Singh Drugs Controller General (India) Meeting With Ambassadors / High Commissioners of African Countries 24
Drug Regulations in India Dr. Surinder Singh Drugs Controller General (India) Meeting With Ambassadors / High Commissioners of African Countries 24 th April 2009, New Delhi Flow of presentation About Indian
Procurement and Supply Management
November 2009 Guide to the Global Fund s Policies on Procurement and Supply Management List of Terms ARVs ERP GDF GLC LFA PR PSM TB TRIPS UNDP UNFPA UNICEF WHO WHOPES antiretrovirals Expert Review Panel
Unedited version adopted by the 45th WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organization 2010
GUIDELINE ON SUBMISSION OF DOCUMENTATION FOR A MULTISOURCE (GENERIC) FINISHED PHARMACEUTICAL PRODUCT (FPP): PREPARATION OF PRODUCT DOSSIERS (PDS) IN COMMON TECHNICAL DOCUMENT (CTD) FORMAT Unedited version
WHO Medicines Strategy. Countries at the core 2004 2007. World Health Organization
WHO Medicines Strategy Countries at the core 2004 2007 World Health Organization Expanding access to essential medicines Scaling up access to essential medicines especially for HIV/AIDS, tuberculosis and
I N T E R A G E N C Y G U I D E L I N E S. a model quality assurance system for procurement agencies
I N T E R A G E N C Y G U I D E L I N E S a model quality assurance system for procurement agencies WHO/PSM/PAR/2007.3 a model quality assurance system for procurement agencies Recommendations for quality
Pharmaceutical Quality Management System: Current Concept
Pharmaceutical Quality Management System: Current Concept Neetu Dubey 1, *, Himanshu Gupta 3, R.K. Sharma 2, Nitin Dubey 1, Nidhi Dubey 4 1. IPS Academy, Indore, Madhya Pradesh, India. 2. Prestige Institute
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry CLEANING VALIDATION Instructors Loh Kean Chong Rick Ng Date and Time
Technical guidance note for Global Fund HIV proposals in Round 11
Technical guidance note for Global Fund HIV proposals in Round 11 UNAIDS I World Health Organization I August 2011 Rationale for including the development of a system in the proposal With the global momentum
UPDATE BY: DR. FRANCIS RUNUMI AG.DHS(P&D)
UPDATE BY: DR. FRANCIS RUNUMI AG.DHS(P&D) 1 Introduction Draft Bill Highlights Challenges Next Steps 2 Introduction Health care delivery is affected by: 1. High population growth rate (3.4%) 2. Changing
Procurement. Supply chain management. Inventory. IT Modern management. Medical treatment. Optimize. Hospital. model of medical services
Current Situation and Prospects of Supply Chain in Chinese Healthcare industry Prof. Gao Yanjie Ministry of Health, P.R. China 1 Necessity Hospital Supply chain management IT Modern management Optimize
Job description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37.
Job description Job title Directorate Pay band Responsible to Base/location Process Engineer Production SEO Process Engineering Manager Porton Hours/sessions per week 37.5 Job type Permanent INTRODUCTION
Earlier, safer and simpler antiretroviral therapy can push the HIV epidemic into irreversible decline. -WHO Director-General Dr.
1616 Fort Myer Drive, 12th Floor Arlington, Virginia 22209-3100 USA www.scms.pfscm.org Telephone: +1.571.227.8600 Fax: +1.571.227.8601 SCMS Supply Lines August 2013 Content: Feature Article Trends News
The objectives of the Sri Lankan National Medicinal Drug Policy are
NATIONAL MEDICINAL DRUG POLICY FOR SRI LANKA Preamble Sri Lanka had a partly written Drug Policy from the 1960s. It was written as elements of a policy, beginning from selection of drugs for the government
Content. Introduction: Health in Zimbabwe. PSM Zimbabwe. Pag 3. Pag 4. Zimbabwe s Response: Key Achievements. Pag 5
Content Introduction: Health in Zimbabwe Zimbabwe s Response: Key Achievements Strengthening the Procurement and Supply Chain in Zimbabwe Identification of Needs Central Storage and Distribution: The National
Annex 7 Guidelines on pre-approval inspections
World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the
Pharmaceutical Wholesaler Site Inspection Checklist
Pharmaceutical Wholesaler Site Inspection Checklist Date and time of inspection: Legal business name and plant name: Location (address): Phone number: Fax number: Email address: Web site URL: Contact Person:
Unilever Supplier Qualification System (USQS) PI Supplier Information Pack SQA Audit
Unilever Supplier Qualification System (USQS) PI Supplier Information Pack SQA Audit July 2013 Table of Contents Introduction... 2 Booking Your Quality Audit... 3 Step 1. Selecting your Audit House...
U.S. President s Malaria Initiative (PMI) Approach to Health Systems Strengthening
U.S. President s Malaria Initiative (PMI) Approach to Health Systems Strengthening What is Health System Strengthening? Strengthening health systems means supporting equitable and efficient delivery of
UGANDA HEALTH CARE SYSTEM
UGANDA HEALTH CARE SYSTEM Community and Home based Rehabilitation Course Julius Kamwesiga KI May 2011 Objectives 1. Define a Health System 2. Describe how Ugandan Health care System is organized 3. Outline
RISK MANAGEMENT SOLUTIONS
RISK SOLUTIONS COLLATERAL AND BASEL II COMPLIANCE The Basel Committee has released a detailed set of requirements dealing with bank reserve requirements and risk-weighting in relation to international
Health Care Services
Abdulaziz H Al Saggabi, BSc, MSc, PharmD, Director, Drug Policy & Economics Center National Guard Health Affair & President ISPOR Saudi Arabia Chapter Presentation Outline y Background of Saudi Arabia
FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005)
FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005) Dr.R.MANAVALAN, M.Pharm., Ph.D. Professor and Research Director, Department of Pharmaceutics,
Richard H. Needle, PhD, MPH Lin Zhao, PhD candidate (UCSF School of Nursing) CSIS Africa Program Roundtable June 10, 2010
Richard H. Needle, PhD, MPH Lin Zhao, PhD candidate (UCSF School of Nursing) CSIS Africa Program Roundtable June 10, 2010 Reference Group to the United Nations on HIV and Injecting Drug Use 2010 Mathers:
Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015
Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015 *QP Code of Practice 2008 updated Aug15 Page 1 of 13 Code of Practice for Qualified Persons 1. INTRODUCTION 2.
Auditing as a Component of a Pharmaceutical Quality System
Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a
The global classroom: Training the world s healthcare professionals
The global classroom: Training the world s healthcare professionals Dr Stuart Anderson Associate Dean of Studies London School of Hygiene and Tropical Medicine 1 Overview Describe the main education and
Clinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.
Clinical Trial Trends Outline Complexity for Supply Chain Scott Ohanesian, VP Commercial Operations APAC Email: [email protected] 29 May 2013 Biotechnology Sales on the Rise Source: EvaluatePharma
Engineering for the new pharma reality
NNE Pharmaplan is an international company specialised in pharma engineering. We help pharmaceutical companies bring products to market by providing flexible, compliant and future-proof solutions. We have
TERMS OF REFERENCE FOR CERTIFICATION BODIES (CBs)
TERMS OF REFERENCE FOR CERTIFICATION BODIES (CBs) AUGUST 2014 1. Introduction National Information Technology Authority (NITA-U) was established by the Act of Parliament (National Information Technology
How To Get A Phd At The University Of Sydney
WELCOME Thank you for your interest in undertaking postgraduate studies at the Marie Bashir Institute for Infectious Diseases and Biosecurity (MBI). In order to process your enquiry we will require the
Recent Updates on European Requirements and what QPs are expected to do
Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status
Content Introduction. Pag 3. Introduction. Pag 4. The Global Fund in Zimbabwe. Pag 5. The Global Fund Grant Portfolio in Zimbabwe.
Content Introduction The Global Fund in Zimbabwe The Global Fund Grant Portfolio in Zimbabwe Capacity Development 2009-2014 Capacity Development and Transition Planning 2014 Overview of the Capacity Development
Annex 7 Guidelines for the preparation of a contract research organization master file
World Health Organization WHO Technical Report Series, No. 957, 2010 Annex 7 Guidelines for the preparation of a contract research organization master file Background 1. General information 2. Quality
UNIVERSITY OF SOUTH AFRICA
UNIVERSITY OF SOUTH AFRICA DEPARTMENT OF HEALTH STUDIES INFORMATION CONCERNING POST GRADUATE PROGRAMMES HONOURS BACHELOR OF ARTS IN HEALTH STUDIES POSTGRADUATE DIPLOMA IN PUBLIC HEALTH MASTER OF PUBLIC
ASHP ACCREDITATION STANDARD FOR PHARMACY TECHNICIAN TRAINING PROGRAMS
ASHP ACCREDITATION STANDARD FOR PHARMACY TECHNICIAN TRAINING PROGRAMS Part I----Administrative Responsibility for the Training Program A. Pharmacy technician training programs may be conducted by health
THEME: PROMOTING GOOD PRACTICES IN DRUG POLICY DEVELOPMENT AND IMPLEMENTATION
Page 1 AFRICAN UNION UNION AFRICAINE UNIÃO AFRICANA Addis Ababa, ETHIOPIA P. O. Box 3243 Telephone 251-11-5517 700 Fax 251-11-5517 844 website: www. africa-union.org 5 th SESSION OF THE AU CONFERENCE OF
PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)
January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal
Foreign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan
Islamic Republic of Afghanistan Ministry of Public Health General Directorate of Pharmaceutical Affairs Foreign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan 2015 Islamic
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry PROJECT MANAGEMENT: RENOVATION OF RESEARCH LABORATORY FOR CELL CULTURE
PDP Funders Group Briefing Paper 3. 1. Background. 2. Methods
PRODUCT DEVELOPMENT PARTNERSHIPS (PDPS): WORKING TOGETHER: COLLABORATIONS BETWEEN PDPS AND PHARMACEUTICAL BIOTECHNOLOGY COMPANIES BASED IN EMERGING AND DEVELOPING ECONOMIES 1. Background Product Development
Health Insurance Systems in Five Sub-Saharan African Countries: Medicines Benefits and Data for Decision-Making
Health Insurance Systems in Five Sub-Saharan African Countries: Medicines Benefits and Data for Decision-Making Carapinha, Joao (1); Ross-Degnan, Dennis (2); Tamer Desta, Abayneh (3); Wagner, Anita (2)
NATIONAL HEALTH ACCOUNTS:
THE REPUBLIC OF UGANDA MINISTRY OF HEALTH NATIONAL HEALTH ACCOUNTS: KEY MESSAGES (FY2010/11 & 2011/12) NATIIONAL HEALTH ACCOUNTS: KEY MESSAGES Introduction The overall purpose of the National Health Accounts
Operating Procedures of the PAHO Revolving Fund. for the Purchase of Vaccines, Syringes, and Other Related Supplies
Operating Procedures of the PAHO Revolving Fund for the Purchase of Vaccines, Syringes, and Other Related Supplies May 2011 Operating Procedures of the Revolving Fund for the Purchase of Vaccines, Syringes,
Tomorrow s Health Care Today
Tomorrow s Health Care Today Our Vision Healthcare that meets international standards Our Mission We are committed to improving standards of health care in Uganda through innovation, applied research,
Global Update on HIV Treatment 2013: Results, Impact and Opportunities
June 2013 Global Update on HIV Treatment 2013: Results, Impact and Opportunities WHO/UNAIDS/UNICEF v2 Outline Results: Progress towards Global Targets - Antiretroviral treatment - Prevention of mother-to-child
DEVELOPING WORLD HEALTH PARTNERSHIPS DIRECTORY
DEVELOPING WORLD HEALTH PARTNERSHIPS DIRECTORY OVER 250 HEALTH PARTNERSHIPS THAT MAKE A DIFFERENCE TO PEOPLE S LIVES The global health community needs to overcome both new and current challenges in the
Challenges & opportunities
SCALING UP FAMILY PLANNING SERVICES IN AFRICA THROUGH CHRISTIAN HEALTH SYSTEMS Challenges & opportunities Samuel Mwenda MD Africa Christian Health Associations Platform/CHAK Presentation outline Introduction
Industry Implications of Pharmaceutical Quality ICH Guidelines
EIPG General Assembly Industry Implications of Pharmaceutical Quality ICH Guidelines 20 th April 2008 Pharmaceutical Quality Develop a harmonised pharmaceutical quality system applicable across the lifecycle
VII. IMPACT ON THE HEALTH SECTOR
VII. IMPACT ON THE HEALTH SECTOR The HIV/AIDS epidemic has posed and will continue to pose tremendous challenges to the health systems of the developing countries, especially in the most severely affected
NGO self-regulation: enforcing and balancing accountability. Robert Lloyd and Lucy de las Casas
NGO self-regulation: enforcing and balancing accountability Robert Lloyd and Lucy de las Casas Increasing visibility and increasing criticism, among other factors, have led to growing pressure on NGOs
SADC PHARMACEUTICAL PROGRAMME SADC PHARMACEUTICAL BUSINESS PLAN 2007-2013
SADC PHARMACEUTICAL PROGRAMME SADC PHARMACEUTICAL BUSINESS PLAN 2007-2013 SADC SECRETARIAT 27 TH JUNE 2007 ACRONYMS AIDS : Acquired Immunodeficiency Syndrome Antiretroviral ARV : Antiretroviral cgmp :
Overview. Health Science Authority. Implementation of ICH guideline in Singapore. Singapore s experience
ICH and Singapore Dr Christina Lim Deputy Group Director, Health Product Regulation Group Senior Advisor, International Collaboration Health Sciences Authority Singapore November 2008 Overview Health Science
Chlorhexidine for Umbilical Cord Care: A new, low-cost intervention to reduce newborn mortality
Chlorhexidine for Umbilical Cord Care: A new, low-cost intervention to reduce newborn mortality Cord care with 7.1% chlorhexidine digluconate saves newborn lives Key facts: Each year 3 million newborns
Marieme Ba for CAAST-NET + 1 st stakeholder meeting Entebbe November 2014
Coming together is a beginning, keeping together is progress, working together is success. - Henry Ford - Considering the clinical research industry as an area for enhanced public-private sector collaboration
Cold Chain Shipping: Protecting Temperature Sensitive Products. Diane McLean Pfizer Global Manufacturing
Cold Chain Shipping: Protecting Temperature Sensitive Products Diane McLean Pfizer Global Manufacturing January 8, 2009 1 What is Cold Chain? The term cold chain or cold chain management refers to controlled